James L. Atkins
Uniformed Services University of the Health Sciences
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by James L. Atkins.
Shock | 2005
Michael T. Handrigan; Timothy B. Bentley; James D. Oliver; Lindita S. Tabaku; J. Robert Burge; James L. Atkins
Hypotensive resuscitation (Hypo) has been considered an alternate resuscitation strategy in clinical settings that prevent the application of standard Advanced Trauma Life Support care. However, validation of this approach when used for prolonged periods of time remains to be demonstrated. The purpose of this study was to evaluate prolonged Hypo as an alternative to standard resuscitation using various currently available resuscitative fluids. Unanesthetized, male Sprague-Dawley rats underwent computer-controlled hemorrhagic shock and resuscitation. There were six experimental groups; nonhemorrhage (NH), nonresuscitated control (C), Hypo with lactated Ringers (HypoLR), Hypo with Hextend®, 6% hydroxyethyl starch in a balanced salt solution (HEX), Hypo with PolyHeme®, a polymerized hemoglobin solution (HBOC), or standard resuscitation with LR (StandLR). Animals were bled over 15 min to a mean arterial blood pressure (MAP) of 40 mmHg where the blood pressure (BP) was held for 30 min. Hypo groups were resuscitated to 60 mmHg for 4 h followed by further resuscitation to 80 mmHg. StandLR rats were resuscitated to 80 mmHg immediately after the hemorrhage period. Animals were monitored until death or they were sacrifice at 24 h. Prolonged Hypo with HEX or LR resulted in a trend toward improved 24-h survival compared with C (71%, 65%, and 48%, respectively), and performed at least as well as StandLR (58% survival). HEX required significantly less intravenous fluid (0.7x total estimated blood volume [EBV]) compared with HypoLR (1.9x EBV) and StandLR (3.2x EBV) (P < 0.05). Although HBOC required the smallest fluid volume (0.4x EBV), survival was no better than C and it resulted in the most significant acidosis. These results support the decision to use Hextend for Hypo, a strategy currently being applied on the battlefield.
Shock | 2008
James L. Atkins; Rasha Hammamieh; Marti Jett; Nikolai V. Gorbunov; Ludmila Asher; Juliann G. Kiang
Mesenteric lymph contains unidentified proinflammatory mediators that increase in concentration after hemorrhage. In the search for candidate mediators, we examined mesenteric lymph for the presence of proinflammatory substances that are known to be produced in the gut: (a) antimicrobial peptides and antimicrobial proteins produced in the Paneth cells of the intestine (&agr;-defensin 4, secretory phospholipase A2 [sPLA2], and Reg 2 protein) and (b) asymmetric dimethylarginine (ADMA), an endogenous inhibitor of NOS. Anesthetized male rats were hemorrhaged to 40 mmHg and maintained at that pressure by intermittent blood withdrawal until the pressure fell to less than 40 mmHg (decompensation) at which point they were resuscitated with three times the shed blood volume of Ringers lactate solution administered over 1 h. Mesenteric lymph samples were analyzed for ADMA by enzyme-linked immunosorbent assay and for &agr;-defensin 4, sPLA2, and Reg2 by Western blotting. Protein concentration in lymph was unchanged by hemorrhage, but &agr;-defensin 4 increased significantly (12-fold greater than control) as did ADMA (2-fold greater than control). The sPLA2 could not be detected in lymph, and Reg 2 was unchanged during hemorrhage. During resuscitation, lymph flow tended to increase, but the concentration of ADMA and &agr;-defensin 4 by volume did not increase. Reg 2 decreased during resuscitation. The results indicate that ADMA and immunoreactive product to &agr;-defensin 4 may contribute to the increase in inflammatory activity of mesenteric lymph during hemorrhage, but they are unlikely to be the mediators responsible for the increase in the concentration of inflammatory mediators in postresuscitation lymph.
Journal of Biological Chemistry | 2003
Vishal G. Warke; Madhusoodana P. Nambiar; Sandeep Krishnan; Klaus Tenbrock; David A. Geller; Nicolas P. Koritschoner; James L. Atkins; Donna L. Farber; George C. Tsokos
Journal of Applied Physiology | 2004
Juliann G. Kiang; Phillip D. Bowman; Brian W. Wu; Nyasa Hampton; Andrew G. Kiang; Baiteng Zhao; Yuang-Taung Juang; James L. Atkins; George C. Tsokos
Journal of Applied Physiology | 2005
Juliann G. Kiang; Xinyue Lu; Lindita S. Tabaku; Timothy B. Bentley; James L. Atkins; George C. Tsokos
Journal of Applied Physiology | 2006
James L. Atkins; Billy W. Day; Michael T. Handrigan; Zhe Zhang; Motilal B. Pamnani; Nikolai V. Gorbunov
American Journal of Physiology-gastrointestinal and Liver Physiology | 2006
Juliann G. Kiang; Phillip D. Bowman; Xinyue Lu; Yansong Li; Xuan Z. Ding; Baiteng Zhao; Yuang-Taung Juang; James L. Atkins; George C. Tsokos
The FASEB Journal | 2008
James L. Atkins; Chae-Hyuk Lee; Elizabeth Barrows; Peter Quinn; Raoul Gonzales; James D. Oliver
Archive | 2007
James L. Atkins; Michael T. Handrigan; David Burris
Shock | 2004
J. G. Kianq; X. Lu; Lindita S. Tabaku; George C. Tsokos; James L. Atkins; Timothy B. Bentley